Market Exclusive

Analyst Upgrades – AstraZeneca (NYSE:AZN) Stock Gets Upgraded By Jefferies Group from Hold to Buy

Analyst Ratings For AstraZeneca (NYSE:AZN)

Today, AstraZeneca (NYSE:AZN) stock received an upgrade by Jefferies Group from Hold to Buy with a price target of $36.70.

Some recent analyst ratings include

Dividend information for AstraZeneca (NYSE:AZN)

AstraZeneca (NYSE:AZN) pays an annual dividend of $1.37 with a yield of 3.96% and an average dividend growth of -21.20% based on a 3 Year Average..

Dividend History for AstraZeneca (NYSE:AZN)


Recent Trading Activity for AstraZeneca (NYSE:AZN)
Shares of AstraZeneca closed the previous trading session at with 34.83000183105469 shares trading hands.

Exit mobile version